Continuous subcutaneous insulin infusion vs multiple daily injections in pregnant women with type 1 diabetes mellitus: a systematic review and meta-analysis of randomised controlled trials and observational studies | Zendy

P Rys | Zendy; Agnieszka H. LudwigSłomczyńska | Zendy; Katarzyna Cyganek | Zendy; Maciej T. Małecki | Zendy

Open Access

Continuous subcutaneous insulin infusion vs multiple daily injections in pregnant women with type 1 diabetes mellitus: a systematic review and meta-analysis of randomised controlled trials and observational studies

Author(s) -

P Rys,

Agnieszka H. LudwigSłomczyńska,

Katarzyna Cyganek,

Maciej T. Małecki

Publication year - 2018

Publication title -

european journal of endocrinology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.897

H-Index - 148

eISSN - 1479-683X

pISSN - 0804-4643

DOI - 10.1530/eje-17-0804

Subject(s) - medicine , observational study , meta analysis , randomized controlled trial , insulin , diabetes mellitus , type 1 diabetes , type 2 diabetes mellitus , endocrinology

Randomised controlled trials (RCTs) have shown an advantage of continuous subcutaneous insulin infusion (CSII) over multiple daily injections (MDI) in the general type 1 diabetes mellitus (T1DM) population. RCT data on T1DM management in pregnancy remain limited.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research